Glaukos EPS - Earnings per Share 2014-2024 | GKOS

Glaukos annual and quarterly earnings per share history from 2014 to 2024. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
  • Glaukos EPS for the quarter ending March 31, 2024 was $-0.82, a 13.89% increase year-over-year.
  • Glaukos EPS for the twelve months ending March 31, 2024 was $-2.88, a 1.37% decline year-over-year.
  • Glaukos 2023 annual EPS was $-2.78, a 33.01% increase from 2022.
  • Glaukos 2022 annual EPS was $-2.09, a 95.33% increase from 2021.
  • Glaukos 2021 annual EPS was $-1.07, a 60.37% decline from 2020.
Glaukos Annual EPS
2023 $-2.78
2022 $-2.09
2021 $-1.07
2020 $-2.70
2019 $0.37
2018 $-0.37
2017 $0.00
2016 $0.12
2015 $-2.13
2014 $-5.29
2013 $-6.21
Glaukos Quarterly EPS
2024-03-31 $-0.82
2023-12-31 $-0.75
2023-09-30 $-0.63
2023-06-30 $-0.68
2023-03-31 $-0.72
2022-12-31 $-0.66
2022-09-30 $-0.58
2022-06-30 $-0.96
2022-03-31 $0.11
2021-12-31 $-0.46
2021-09-30 $0.13
2021-06-30 $-0.38
2021-03-31 $-0.36
2020-12-31 $-0.21
2020-09-30 $-0.35
2020-06-30 $-0.90
2020-03-31 $-1.24
2019-12-31 $0.95
2019-09-30 $-0.37
2019-06-30 $-0.17
2019-03-31 $-0.04
2018-12-31 $0.05
2018-09-30 $-0.19
2018-06-30 $-0.15
2018-03-31 $-0.08
2017-12-31 $0.04
2017-09-30 $0.04
2017-06-30 $-0.10
2017-03-31 $0.02
2016-12-31 $0.00
2016-09-30 $0.03
2016-06-30 $0.06
2016-03-31 $0.03
2015-12-31 $9.30
2015-09-30 $-0.07
2015-06-30 $-10.96
2015-03-31 $-0.40
2014-12-31 $-1.94
2014-09-30 $-0.64
2014-06-30 $-0.90
2014-03-31 $-1.83
2013-12-31 $0.00
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $5.640B $0.315B
Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $216.032B 26.18
Intuitive Surgical (ISRG) United States $152.181B 91.68
Edwards Lifesciences (EW) United States $54.336B 35.36
Alcon (ALC) Switzerland $44.340B 31.77
DexCom (DXCM) United States $43.972B 66.61
IDEXX Laboratories (IDXX) United States $40.591B 47.58
IQVIA Holdings (IQV) United States $39.007B 22.63
STERIS (STE) Ireland $21.408B 25.01
SONOVA HOLDING (SONVY) Switzerland $18.171B 0.00
Waters (WAT) United States $17.159B 25.22
Hologic (HOLX) United States $16.915B 18.92
Fresenius Medical Care AG KGaA (FMS) Germany $11.449B 13.36
Sysmex ADR (SSMXY) Japan $9.944B 31.18
Teleflex (TFX) United States $9.455B 14.72
Globus Medical (GMED) United States $9.101B 26.68
Masimo (MASI) United States $6.846B 39.37
Penumbra (PEN) United States $6.761B 76.83
TransMedics (TMDX) United States $4.628B 439.09
Integer Holdings (ITGR) United States $3.849B 23.26
PROCEPT BioRobotics (PRCT) United States $3.017B 0.00
LivaNova (LIVN) United Kingdom $2.949B 17.51
Inari Medical (NARI) United States $2.673B 0.00
Nihon Kohden (NHNKY) Japan $2.599B 13.77
Tandem Diabetes Care (TNDM) United States $2.582B 0.00
Elekta AB (EKTAY) Sweden $2.436B 18.68
Integra LifeSciences Holdings (IART) United States $2.351B 10.25
RxSight (RXST) United States $2.063B 0.00
Veracyte (VCYT) United States $1.754B 0.00
Alphatec Holdings (ATEC) United States $1.389B 0.00
Silk Road Medical (SILK) United States $1.061B 0.00
Artivion (AORT) United States $0.965B 92.52
OPKO Health (OPK) United States $0.913B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.887B 17.26
OrthoPediatrics (KIDS) United States $0.677B 0.00
Pulse Biosciences (PLSE) United States $0.584B 0.00
IRadimed (IRMD) United States $0.542B 30.37
Paragon 28 (FNA) United States $0.509B 0.00
Mesa Laboratories (MLAB) United States $0.492B 14.58
SiBone (SIBN) United States $0.492B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.488B 0.00
Pacific Biosciences Of California (PACB) United States $0.395B 0.00
Treace Medical Concepts (TMCI) United States $0.359B 0.00
AxoGen (AXGN) United States $0.316B 0.00
Nevro (NVRO) United States $0.308B 0.00
Sight Sciences (SGHT) United States $0.307B 0.00
Tactile Systems Technology (TCMD) United States $0.269B 9.19
Semler Scientific (SMLR) United States $0.245B 12.42
CVRx (CVRX) United States $0.231B 0.00
Delcath Systems (DCTH) United States $0.229B 0.00
AngioDynamics (ANGO) United States $0.227B 0.00
EDAP TMS S.A (EDAP) France $0.198B 0.00
NeuroPace (NPCE) United States $0.192B 0.00
Inogen (INGN) United States $0.187B 0.00
908 Devices (MASS) United States $0.180B 0.00
Accuray (ARAY) United States $0.169B 0.00
Alpha Tau Medical (DRTS) Israel $0.153B 0.00
ClearPoint Neuro (CLPT) United States $0.151B 0.00
Yubo Biotech (YBGJ) China $0.138B 0.00
Atossa Genetics (ATOS) United States $0.135B 0.00
KORU Medical Systems (KRMD) United States $0.130B 0.00
Spectral Diagnostics (EDTXF) Canada $0.103B 0.00
Sensus Healthcare (SRTS) United States $0.081B 17.10
EnVVeno Medical (NVNO) United States $0.071B 0.00
Monogram Orthopaedics (MGRM) United States $0.068B 0.00
InspireMD (NSPR) Israel $0.063B 0.00
Hyperfine (HYPR) United States $0.060B 0.00
T2 Biosystems (TTOO) United States $0.058B 0.00
SEP Acquisition (SEPA) United States $0.056B 0.00
Neuronetics (STIM) United States $0.053B 0.00
LENSAR (LNSR) United States $0.048B 0.00
Envoy Medical (COCH) United States $0.046B 0.00
Vicarious Surgical (RBOT) United States $0.044B 0.00
Lucid Diagnostics (LUCD) United States $0.042B 0.00
DarioHealth (DRIO) United States $0.036B 0.00
Precision Optics (POCI) United States $0.036B 0.00
ReWalk Robotics (LFWD) Israel $0.035B 0.00
Rapid Micro Biosystems (RPID) United States $0.032B 0.00
Spectral AI (MDAI) United States $0.029B 0.00
Accelerate Diagnostics (AXDX) United States $0.028B 0.00
Pixie Dust Technologies (PXDT) Japan $0.022B 0.00
Aspira Women's Health (AWH) United States $0.020B 0.00
Autonomix Medical (AMIX) United States $0.020B 0.00
Ekso Bionics Holdings (EKSO) United States $0.018B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.017B 0.00
QT Imaging Holdings (QTI) United States $0.016B 0.00
Microbot Medical (MBOT) United States $0.015B 0.00
NexGel (NXGL) United States $0.013B 0.00
Check-Cap (CHEK) Israel $0.012B 0.00
PAVmed (PAVM) United States $0.007B 0.00
Venus Concept (VERO) Canada $0.005B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
Helius Medical Technologies (HSDT) United States $0.004B 0.00
Avinger (AVGR) United States $0.003B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Dynatronics (DYNT) United States $0.002B 0.00
ENDRA Life Sciences (NDRA) United States $0.001B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00